Evidence From a Systematic Review of Non-alcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD) Fueling Cardiovascular Risk
Cureus · 04.08.2025
DOI: 10.7759/cureus.89355 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 04.08.2025. Verfasst von Nehal K Bhatt und 7 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Pramukhswami Medical College, Karamsad, IND. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine, Pramukhswami Medical College, Karamsad, IND.
- Internal Medicine, Sir H.N. Reliance Foundation Hospital and Research Centre, Mumbai, IND.
- Internal Medicine, Jawaharlal Nehru Medical College, Belagavi, IND.
- Internal Medicine, Government Erode Medical College and Hospital, Erode, IND.
- Medicine, Gandhi Medical College, Secunderabad, IND.
- Nephrology, St Helier Hospital, London, GBR.
Zitieren
APA
Bhatt, N. K., Agarwal, Y., Neelakantan Ramaswamy, S., Bendagiri Matam, M., Harikrishnan, S., Chand, S., Bhatt, H., & Malasevskaia, I. (2025). Evidence From a Systematic Review of Non-alcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD) Fueling Cardiovascular Risk. Cureus. https://doi.org/10.7759/cureus.89355
Vancouver
Bhatt NK, Agarwal Y, Neelakantan Ramaswamy S, Bendagiri Matam M, Harikrishnan S, Chand S, et al. Evidence From a Systematic Review of Non-alcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD) Fueling Cardiovascular Risk. Cureus. 2025. doi:10.7759/cureus.89355
BibTeX
@article{Bhatt2025,
author = {Bhatt, Nehal K and Agarwal, Yashasvi and Neelakantan Ramaswamy, Sanathanan and Bendagiri Matam, Manvitha and Harikrishnan, Samyuktha and Chand, Shalvin and Bhatt, Hetavi and Malasevskaia, Iana},
title = {Evidence From a Systematic Review of Non-alcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD) Fueling Cardiovascular Risk},
journal = {Cureus},
year = {2025},
doi = {10.7759/cureus.89355}
}
EUVIMED